Mike Moyer
Host, Investor Relations at LifeSci Advisors for Protallix BioTherapeutics
Replay available
Protalix BioTherapeutics, Inc. (DE) (AMEX: PLX) Q2 2026 earnings conference call, held 2026-08-12. Replay captured from the company's public earnings webcast.

Host, Investor Relations at LifeSci Advisors for Protallix BioTherapeutics
Analyst, Zacks Investment Research
Analyst, H.C. Wainwright & Co.
President and Chief Executive Officer
Senior Vice President and Chief Financial Officer
Watch the replay and follow the connected company analysis, news, and investor updates for Protalix Biotherapeutics, Inc. (de).
WEBVTT 00:00:00.031 -- 00:00:05.156 Good morning, ladies and gentlemen, and welcome to the Protallix BioTherapeutics 00:00:05.156 -- 00:00:10.541 Second Quarter 2026 Financial and Business Results Conference Call. 00:00:10.541 -- 00:00:14.064 As a reminder, this conference is being recorded. 00:00:14.064 -- 00:00:17.147 I will now turn the conference over to your host, Mr. 00:00:17.147 -- 00:00:21.751 Mike Moyer of LifeSci Advisors, Investor Relations for Protallix. 00:00:21.751 -- 00:00:24.172 Please go ahead. 00:00:24.914 -- 00:00:30.219 Thank you, Operator, and welcome to the Portalix BioTherapeutics Q2 2026 Financial 00:00:30.219 -- 00:00:32.641 Results and Business Update Conference Call. 00:00:32.641 -- 00:00:37.685 With me today are Dror Bashan, President and CEO, and Gilad Mamlok, Senior 00:00:37.685 -- 00:00:40.367 Vice President and Chief Financial Officer. 00:00:40.367 -- 00:00:43.670 Press release announcing the financial results and corporate updates was issued this 00:00:43.670 -- 00:00:46.492 morning and is available now on the Portalix website. 00:00:46.492 -- 00:00:50.576 Please take a moment to read the disclaimer about forward-looking statements in the press 00:00:50.576 -- 00:00:54.833 release. The earnings release and this conference Thank you Mike, and thank you everyone 00:00:54.833 -- 00:00:58.214 for joining me this morning. 00:01:21.272 -- 00:01:26.093 Our results today reflect the strengths of our profitable commercial partnerships, and 00:01:26.093 -- 00:01:29.714 we remain confident in our outlook for this year. 00:01:29.714 -- 00:01:35.115 We enter the second half of 2026 with El Pablos sales through Chiesi, continuing 00:01:35.115 -- 00:01:40.596 to drive growth of our business. Gilad will walk through the financial details, 00:01:40.59...